Q4 2025 13F Holders as of 31 Dec 2025
-
Type / Class
-
Equity / COM
-
Shares outstanding
-
146,614,676
-
Total 13F shares
-
1,895,214
-
Share change
-
-33,740
-
Total reported value
-
$333,930,242
-
Price per share
-
$175.99
-
Number of holders
-
155
-
Value change
-
+$1,578,641
-
Number of buys
-
71
-
Number of sells
-
52
Institutional Holders of BIOGEN INC. - COM (BIIB) as of Q4 2025
As of 31 Dec 2025,
BIOGEN INC. - COM (BIIB) was held by
155 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,895,214 shares.
The largest 10 holders included
MASSACHUSETTS FINANCIAL SERVICES CO /MA/, SG Americas Securities, LLC, Aberdeen Group plc, BANQUE PICTET & CIE SA, Dakota Wealth Management, Generali Investments CEE, investicni spolecnost, a.s., Czech National Bank, NISA INVESTMENT ADVISORS, LLC, WEALTH ENHANCEMENT ADVISORY SERVICES, LLC, and NorthCrest Asset Manangement, LLC.
This page lists
155
institutional shareholders reporting positions in this security
for the Q4 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.